HYDERABAD, India, September 17, 2012 /PRNewswire/ --
The Pharma E&L event in Mumbai was a great success. R Saravanan, Analytical General Manager, Mylan Laboratories Limited, commented, "I really enjoyed the seminar. It was simple, straightforward and had ideas that were do-able and very worthwhile. A great speaker line-up and professionally conducted event. Excellent."
He wasn't the only one who found the proceedings to be practical as Jiterndra Parmar, General Manager of Zydus Cadila (Cardila Healthcare Limited) also remarked, "The conference was useful, particularly from the background and theory aspects. There were useful practical examples from the experts, which is very important."
Regulatory affairs workers at Cipla stated, "We have already implemented our learnings from the Mumbai event," showing the importance of the event in today's current market.
After receiving this phenomenal response from the event in Mumbai, CPhI is glad to announce Pharma Extractables and Leachables, Hyderabad, India, taking place from 28-30 November 2012. This 2-day strategic conference will delve deeper into regulatory and analytical challenges in E&L. It also includes an exclusive seminar on overcoming E&L challenges in formulations.
This highly technical event has received a lot of interest and has already confirmed industry leaders to present including Kona Srinivas, Daiichi Sankyo, Arvind Mishra, Cadila Pharmaceuticals, Bharathi Ramesh, Director -Operations, Integrated Global Regulatory Services, Ivy Louis, Founder Director, Vienni Training & Consulting, Dr Piet Christiaens, Dr Ir Anja Cerstiaens, Dr Lothar Habel and Ir Karen Pieters from Toxikon, the Platinum Sponsor and many more.
Apart from an expert line-up of speakers, there will be two exclusive audio-video presentations from Diane Paskiet, Chair, Leachables and Extractables Work Group, PQRI and Dennis Jenke, Baxter Distinguished Scientist, Baxter Healthcare Corporation.
This event will feature in-depth discussions on the specific regulatory and analytical challenges faced with respect to extractables and leachables. One full-day is dedicated to regulatory challenges and will clarify complex E&L requirements to achieve global regulatory compliance, alongside practical case studies on understanding and overcoming country specific E&L requirements. The second day focuses on the latest analytical solutions in E&L, cost-effective and time-saving analytical techniques to effectively identify and extract E&L, and how to implement effective safety qualification and robust toxicological risk assessment processes.
An important addition to this event is the interactive one-day seminar focusing on the significance of the extractables and leachables study and its potential sources, compatibility and stability study of product with its packaging material and systematic quality control approach for new product development.
Visit www.extractablesandleachables.com/pr to view the complete programme.
CPhI is a UBM brand, and is the largest and most important meeting place for the Indian pharma industry. Each year CPhI attracts around 850 exhibitors and 30,000 visitors to the show, providing us with an unrivalled reach to all the key decision makers in the Indian Pharma industry.
UBM is a global live media and B2B communications, marketing service and data provider founded in 1918. We help organisations make connections, communicate their proposition and do business effectively. We enable professional people in more than 40 countries around the world to connect and engage with each other, with the markets they serve and with the information they need to succeed. And we do this by whatever means works best - at live events, through digital media or in publications. Company Size: 6000-6500 employees; Website: http://www.ubm.com/.
Primary Media Contact: Asan Bano, firstname.lastname@example.org, 91-22-4046 1466
SOURCE UBM India Pvt. Ltd.